Discover the simplicity and effectiveness of one of the top weight loss programs prescribing Foundayo™ for weight loss!
Benefits of Our Weight Loss Program
Our Life IV Weight Loss program offers a comprehensive approach to weight loss, ensuring that you receive the best possible support and resources to achieve your goals. Here are some of the key benefits of our program:
| Benefit | Description |
|---|---|
| Personalized Plans | Customized weight loss plans tailored to your unique needs and lifestyle. |
| Expert Guidance | Support from experienced medical professionals, including Dr. Allie Cherfan and Dr. Victor Cherfan. |
| Comprehensive Approach | Combining motivation, calorie restriction, tracking, and medication for optimal results. |
| Telehealth Services | Convenient access to telehealth registered dieticians through our partnership with Nourish®. |
| Insurance Assistance | Guidance on using insurance to cover commercial products and support for prior authorization. |
| Proven Success | Documented success stories and testimonials from satisfied clients. |
Join the Life IV Weight Loss program today and take the first step towards a healthier, happier you. Our expert team is here to support you every step of the way, ensuring you achieve your weight loss goals effectively and sustainably.
Your Weight Loss Success story starts today!
Book your weight loss consultation today and start your journey towards a healthier, happier you.
Foundayo™ Self-Pay Program
Cash-pay pricing for Foundayo™ starts at approximately $149 per month for the lowest dose (0.8 mg) when purchased through LillyDirect® Pharmacy for eligible patients. Higher strengths are available at higher self-pay prices, typically ranging from $199 to $299 per month, with some of the highest doses costing up to $349 per month if refill requirements are not met.†
Patients with commercial insurance who qualify for the Foundayo™ Savings Card may pay as little as $25 per month.†
Learn more and see if you qualify for self-pay pricing through LillyDirect® Pharmacy by talking with your healthcare provider or visiting the LillyDirect website.
†Self-pay pricing for Foundayo™ (a once-daily oral GLP-1 medication) generally begins at $149/month for the 0.8 mg starting dose, increases to approximately $199/month for mid-level doses, and is typically $299/month for maintenance doses when filled through LillyDirect® Pharmacy. Higher doses may cost up to $349/month without qualifying refill programs. Eligible commercially insured patients may pay as little as $25/month using the Foundayo Savings Card. Prices, eligibility, and terms may vary. See full details at LillyDirect® Pharmacy: https://www.lilly.com/lillydirect/medicines/foundayo
FAQ
How much does Foundayo™ cost?
The cost of Foundayo™ depends on your insurance coverage and prescribed dose. Some patients use insurance, while others choose a self-pay option through the manufacturer via LillyDirect® Pharmacy.
Here’s what you can expect:
| Type | What to Expect |
|---|---|
| Self-Pay (Cash Option) | If you are uninsured or your insurance does not cover weight loss medications, you may purchase Foundayo™ directly through LillyDirect® Pharmacy.
Current manufacturer pricing (subject to change): In some cases, higher doses may cost up to $349 per month depending on refill program eligibility. Foundayo™ is an oral, once-daily GLP-1 medication rather than a weekly injection. View official pricing directly from LillyDirect® Foundayo™ Pricing ↗ |
| Commercial Insurance | Many commercial insurance plans may cover Foundayo™ if medical criteria are met. Coverage varies widely by employer and plan.
If covered, your cost depends on your deductible, copay, or coinsurance. Eligible commercially insured patients may pay as little as $25 per month using the Foundayo™ Savings Card. Learn more at Foundayo™ Savings Information ↗ |
| Medicare | Medicare currently does not typically cover medications prescribed specifically for weight loss, including Foundayo™. |
| Medicaid | Medicaid coverage varies by state. Some states provide coverage for anti-obesity medications, while others do not. |
Simple Cost Summary
If paying out of pocket, most patients can expect a monthly cost between $149 and $299 depending on the prescribed dose, with some higher-dose scenarios reaching up to $349 per month.
This self-pay option is available even if you have insurance but your plan excludes weight loss medications.
Because pricing and savings programs may change, always confirm current pricing directly with the manufacturer ↗
Prior Authorization for Foundayo™
Many insurance plans require prior authorization (PA) before approving Foundayo™. This process confirms that the medication meets your plan’s medical criteria.
- Submission of medical history and current health information
- Verification of BMI and qualifying weight-related conditions
- Insurance review to determine eligibility
At Life IV Weight Loss, our insurance and care coordination team helps patients navigate both insurance and self-pay options. We verify benefits, submit prior authorizations when required, and review affordable alternatives if coverage is denied.
How does Foundayo™ work for weight loss?
Foundayo™ is an FDA-approved once-daily oral medication for chronic weight management that contains orforglipron. It works by activating the GLP-1 (glucagon-like peptide-1) receptor, a natural hormone pathway involved in appetite regulation, blood sugar control, and metabolism.
Unlike injectable GLP-1 medications, Foundayo™ is taken by mouth, offering a non-injectable option for eligible adults.
When used along with a reduced-calorie diet and increased physical activity, Foundayo™ may support meaningful and sustained weight loss.
For full prescribing and medication details, visit the manufacturer’s website ↗
LillyDirect® Foundayo™.
| Mechanism | Description |
|---|---|
| GLP-1 Receptor Activation | Foundayo™ activates the GLP-1 receptor, which helps regulate appetite, food intake, and blood sugar levels. This pathway plays a key role in weight management and metabolic health. Learn more from the manufacturer ↗ LillyDirect®. |
| Appetite Regulation | Foundayo™ works on areas of the brain that control hunger and cravings, helping reduce appetite and support better portion control. |
| Increased Fullness | By slowing gastric emptying, Foundayo™ helps you feel full longer after eating, which may naturally reduce overall calorie intake. |
| Improved Blood Sugar Regulation | Foundayo™ enhances insulin secretion in response to meals and helps stabilize blood sugar levels, which may reduce hunger driven by glucose fluctuations. |
| Supports Long-Term Weight Management | When combined with lifestyle changes, GLP-1 receptor activation has been shown to support clinically meaningful weight loss and ongoing weight maintenance. See full details ↗ Foundayo™ Information. |
Foundayo™ is intended for use in adults with obesity or overweight with at least one weight-related condition. Always refer to the manufacturer for complete safety information, dosing details, and prescribing guidance.
What are the common side effects of Foundayo™?
Foundayo™ is effective for chronic weight management, but like all medications, it may cause side effects. The most common side effects are gastrointestinal and are typically more noticeable when first starting treatment or when increasing the dose. Many patients find these symptoms improve over time as their body adjusts.
For complete safety information, please review the manufacturer’s information ↗
Foundayo™ Medication Information.
| Side Effect | Description |
|---|---|
| Nausea | A feeling of stomach upset or queasiness, most commonly experienced during the early weeks of treatment or after dose increases. |
| Diarrhea | Loose or watery stools that may occur as the digestive system adjusts to the medication. |
| Constipation | Difficulty passing stools, which may occur due to slower gastric emptying. Staying hydrated may help. |
| Vomiting | Episodes of vomiting may occur, particularly during dose escalation, and are often temporary. |
| Abdominal Pain | Stomach discomfort, cramping, or bloating that can occur as digestion slows. |
| Indigestion (Dyspepsia) | Upper abdominal discomfort, fullness, or burning sensations after eating. |
| Decreased Appetite | Reduced hunger is a common effect of GLP-1 medications and contributes to weight loss. |
| Fatigue | Some patients report temporary tiredness as their body adapts to treatment. |
This is not a complete list of side effects. Serious side effects may occur. Always discuss risks, benefits, and your medical history with your healthcare provider. For full safety details, warnings, contraindications, and dosing instructions, refer directly to the manufacturer ↗
LillyDirect® Foundayo™ and
Foundayo™ Savings & Information.
How is Foundayo™ administered?
Foundayo™ is a once-daily oral medication taken by mouth. Unlike injectable GLP-1 medications, Foundayo™ does not require injections, making it a convenient option for eligible patients.
Foundayo™ should always be taken exactly as prescribed by your healthcare provider. For full instructions and details, refer to the manufacturer’s information ↗
LillyDirect® Foundayo™.
| Step | Description |
|---|---|
| Frequency | Take Foundayo™ once daily, at approximately the same time each day, as directed by your healthcare provider. |
| Administration Method | Foundayo™ is taken orally (by mouth) as a tablet. It does not require injection. |
| With or Without Food | Follow your provider’s instructions regarding whether to take Foundayo™ with or without food, as recommendations may vary. |
| Dose Escalation | Your healthcare provider will typically start at a lower dose (such as 0.8 mg daily) and gradually increase the dose over time to help minimize side effects. |
| Missed Dose | If you miss a dose, take it as soon as you remember on the same day. If it is close to your next scheduled dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time. |
| Storage | Store Foundayo™ at room temperature in a dry place, away from excessive heat and moisture. Keep out of reach of children. Refer to the manufacturer for full storage details ↗ LillyDirect®. |
This summary is for informational purposes only and does not replace full prescribing information. Always follow your healthcare provider’s instructions and review complete manufacturer guidance for dosing, administration, and safety details ↗
Foundayo™ Information and
Foundayo™ Savings & Information.
Who is a good candidate for Foundayo™?
Foundayo™ is prescribed for adults who need medical support to achieve and maintain weight loss. It is intended to be used as part of a comprehensive weight management plan that includes a reduced-calorie diet and increased physical activity.
| Criteria | Description |
|---|---|
| Body Mass Index (BMI) | Adults with a BMI of 30 kg/m² or greater (obesity), or 27 kg/m² or greater (overweight) in the presence of at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia. |
| Age | Adults 18 years of age and older. Foundayo™ is not currently indicated for pediatric patients. |
| Weight-Related Conditions | Individuals with obesity-related medical conditions may benefit from treatment as part of a medically supervised weight management program. |
| Preference for Oral Medication | Patients who prefer a once-daily oral option instead of injections may find Foundayo™ to be a convenient alternative. |
| Commitment to Lifestyle Changes | Foundayo™ should be used in combination with a reduced-calorie diet and increased physical activity for best results. |
| Contraindications | GLP-1 receptor agonists, including Foundayo™, are generally not recommended in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Patients with known hypersensitivity to any component of the medication should not use Foundayo™. |
Eligibility for Foundayo™ is determined by a licensed healthcare provider after a full medical evaluation.
For complete prescribing information, warnings, and safety details, refer directly to the manufacturer ↗
Foundayo™ Medication Information
and the official savings and coverage page ↗
Foundayo™ Savings & Coverage
.
WARNING: RISK OF THYROID C-CELL TUMORS
In animal studies, GLP-1 receptor agonists have been associated with thyroid C-cell tumors. It is unknown whether Foundayo™ causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans.
Foundayo™ should not be used in patients with a personal or family history of MTC or in patients with MEN 2.
Counsel patients regarding the potential risk of thyroid tumors and symptoms such as a lump in the neck, trouble swallowing, shortness of breath, or persistent hoarseness.